Brazil In Vitro Diagnostics Market

Brazil In Vitro Diagnostics Market Outlook 2031:

The Brazil in vitro diagnostics market size was valued at USD 1.70 Billion in 2022 and is projected to reach USD 2.53 Billion by 2031, expanding at a CAGR of 4.52% during the forecast period 2023 - 2031. The growth of the market is attributed to the rising interest of the researchers in molecular testing technologies.

In vitro diagnostics is defined as medical equipment that are used by hospital to perform diagnostic tests inside a laboratory. These tests are carried out on blood, urine, and tissue samples taken from a patient's body. Additionally, medical devices that perform in vitro diagnostics require the employment of a variety of technologies to carry out the tests.

Get Free Sample Report

In vitro diagnostics are used to diagnose infectious disorders, diabetes, cancer, cardiac problems, autoimmune diseases, nephrology, and HIV, among other medical conditions. However due to the COVID-19, several in vitro diagnostics services were negatively impacted. As a result, the total impact on the in vitro diagnostics industry was minimal as increasing demand for testing kits offset losses from lower demand for other services and products.

In Vitro Diagnostics Market Trends, Drivers, Restraints, and Opportunities

• Rise in awareness about diagnostic services is driving the market growth.
• Increasing government expenditure on healthcare is anticipated to boost the market expansion.
• The accurate and quick test results supplement of in vitro diagnostics is propelling the growth of the industry.
• Stringent regulations & policies can hamper the market growth.
• Ongoing R&D on vitro diagnostics and lucrative opportunities for key players in the in vitro diagnostics market during the forecast period. 

Scope of the In Vitro Diagnostics Market Report

The report on the Brazil in vitro diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Brazil In Vitro Diagnostics Market Segment Insights

Molecular diagnostics segment is expected to grow at a rapid pace

Based on test types, the market is divided into molecular diagnostics, clinical chemistry, immunodiagnostics, hematology, and others. The molecular diagnostics segment is expected to grow at a rapid pace during the forecast period due to rising prevalence of diabetes.

Moreover, molecular diagnostic equipment evaluates biological markers in the genome and proteome to identify diseases or mutations.

Get Free Sample Report

Reagents segment is projected to expand at a considerable CAGR

On the basis of products, the market is segregated into instrument, reagent, and others. The reagents segment is projected to expand at a considerable CAGR during the forecast period as reagents are a vital part of every in-vitro diagnostic test.

However, the instrument segment is anticipated to hold a key share of the market in the coming years owing to rise in focus  toward launching of new instruments. 

Disposable IVD segment is anticipated to account for a significant market share.

In terms of usability, the market is divided into disposable IVD devices and reusable IVD devices. The disposable IVD devices segment is anticipated to account for a significant market share during the forecast period due to easy availability of devices.

However, the IVD devices segment is projected to expand at a considerable CAGR during the forecast period owing to growing knowledge about the usage of these devices.

Infectious disease segment is expected to expand at a considerable CAGR

On the basis of applications, the market is segregated into infectious disease, cardiology, autoimmune disease, diabetes, cancer/oncology, nephrology, and others.

The infectious disease segment is projected to expand at a considerable CAGR during the forecast period due to rise in incidence of HIV, hepatitis, and other infectious disorders.

Get Free Sample Report

Diagnostic laboratories segment is anticipated to account for a significant market share.

Based on end-users, the market is divided into diagnostic laboratories, hospitals & clinics, and others. The diagnostic laboratories segment is estimated to account for a significant market share during the forecast period.

Diagnostic laboratories employee highly experienced laboratory technicians who can execute complex in vitro diagnostic tests. The hospitals & clinics medical facilities receive a huge number of patient samples for in vitro diagnostic testing.

Segments

The Brazil in vitro diagnostics market has been segmented on the basis of

Test Types

• Clinical Chemistry
• Molecular Diagnostics
• Immunodiagnostics
• Hematology
• Others

 Products

• Instrument
• Reagent
• Others

Usability

• Disposable IVD Devices
• Reusable IVD Devices

 Applications

• Infectious Disease
• Diabetes, Cancer/Oncology
• Cardiology, Autoimmune Disease
• Nephrology
• Others

End-users

• Diagnostic Laboratories
• Hospitals & Clinics
• Others

 Country

• Brazil

Key Players

• Bio-Rad Laboratories Inc.
• Roche Diagnostics
• bioMérieux
• Danaher Corporation
• Becton, Dickinson and Company

Competitive Landscape

Key players competing in the Brazil in vitro diagnostics market are Bio-Rad Laboratories Inc.; Roche Diagnostics; bioMérieux; Danaher Corporation; Becton, Dickinson and Company.

The major companies are concentrating their efforts on growing technical breakthroughs in order to meet client demands, such as completely automated systems that eliminate human operations and consumables while providing quick and precise results.